Success Story: EB1A Success Without RFE! Our Firm Assisted a Scientist and Researcher in Securing Approval
Client’s Testimonial:
“Dear Team, thank you for your help.”
On November 18th, 2025, we received another EB-1A (Alien of Extraordinary Ability) approval for a Scientist and Researcher in the Field of Otolaryngology (Approval Notice).
General Field: Otolaryngology
Position at the Time of Case Filing: Scientist and Researcher
Country of Origin: Georgia
State of Residence at the Time of Filing: Colorado
Approval Notice Date: November 18th, 2025
Processing Time: 5 months, 27 days (Premium Processing Upgrade Requested)
Case Summary:
Our firm is pleased to announce the approval of an EB-1A (Alien of Extraordinary Ability) petition for a distinguished medical researcher in the field of otolaryngology.
With an M.D. in General Medicine, the client has developed deep expertise in otolaryngology, with specialized work spanning sensorineural hearing loss, vestibular disorders, and facial plastic surgery. The client is particularly well-known for research addressing the critical need to enhance surgical outcomes in ear, nose, and throat procedures. As a researcher and clinician, the client now works to advance clinical and translational discoveries in otolaryngology and to ensure that innovative diagnostic and therapeutic protocols continue to evolve for patient benefit.
Research Impact and Global Significance
The client’s body of work delivers essential insights into improving treatment outcomes for complex ENT conditions, advancing modern understanding of auditory and vestibular disorders, and integrating new technologies to strengthen surgical decision-making. This research directly addresses pressing national concerns surrounding patient outcomes, healthcare system efficiency, and long-term disease burden.
The client has produced an extensive research record, including 30 peer-reviewed journal articles (13 first-authored), 12 first-authored editorial letters, 11 case reports (8 first-authored), 4 first-authored conference papers, 24 abstracts (19 first-authored), and 5 first-authored book chapters. This body of work has been cited 153 times, reflecting widespread use of the client’s findings in specialized areas such as auditory health, surgical reconstruction, and vestibular disorder management. The client’s prominent work has significantly informed global research communities through the publication of original clinical protocols, novel diagnostic frameworks, and innovative technology-assisted patient-care strategies.
The client’s impact extends into scientific quality control as well. Having completed at least 100 peer reviews, the client has been repeatedly sought out by high-impact journals for expert evaluation, demonstrating recognition at the highest professional levels.
We also highlighted major competitive funding from organizations such as the National Research Foundation of Korea and the Ministry of Small and Medium-Sized Enterprises and Startups of Korea, clear indicators of national-level scientific trust in the importance of the client’s research.
Expert Endorsements
The petition included four expert Letters of Recommendation, each emphasizing the transformative nature of the client’s work. One expert summarized the client’s impact as follows:
“[Client’s] prowess in otology-neurotology, balance disorders, and tinnitus, along with her extensive surgical expertise and record of publications in prestigious outlets, establishes her inherent value to the U.S.”
These letters came from leading specialists in the field who independently recognized the client’s sustained influence, international reach, and essential role in advancing modern otolaryngology.
EB-1A Approval and Outlook
The successful approval of this EB-1A petition reaffirms NAILG’s strong commitment to supporting extraordinary researchers whose work shapes the future of medical science and improves national healthcare outcomes. We are honored to have worked with this exceptional otolaryngology expert and extend our best wishes as the client continues driving innovation in auditory health, surgical improvement, and evidence-based patient care in the United States.

